Food Science & Nutrition · Nov 16, 2026
Effects of Walnut ( Juglans regia L.) Consumption on Glycemic and Anthropometric Indices in Adults: A Systematic Review and Dose‐Response Meta‐Analysis
By Mashayekhi G, Ashtary‐Larky D, Karimi M et al.
Walnuts ( Juglans regia L.) are nutrient‐dense nuts rich in polyunsaturated fatty acids, fiber, and antioxidant phytochemicals that may influence glucose metabolism and body composition. This systematic review and dose–response meta‐analysis aimed to quantitatively assess the effects of walnut consumption on glycemic indices and anthropometric parameters in adults. A literature search was conducted across PubMed, Scopus, and Web of Science through September 2026. Randomized controlled trials (RCTs) evaluating the effects of walnut supplementation compared with a placebo or control group on fasting blood sugar (FBS), fasting insulin (FI), hemoglobin A1c (HbA1c), HOMA‐IR, body weight (BW), body mass index (BMI), and waist circumference (WC) were included. Weighted mean differences (WMDs) were pooled using random‐effects models. Subgroup analyses, linear and non‐linear dose–response models, and GRADE assessments were performed. Forty‐eight RCTs (56 comparisons) were included. Overall, walnut consumption did not significantly affect FBS, FI, HbA1c, HOMA‐IR, BW, BMI, or WC. Subgroup analyses showed significant reductions in BW among obese individuals and in low‐dose (< 50 g/day) or crossover studies, while FBS increased slightly in participants with baseline FBS < 100 mg/dL. Non‐linear analyses showed significant associations between walnut dose and changes in HbA1c, BW, and WC, and linear regression revealed a positive association between the duration of intervention and FI. According to the GRADE framework, the certainty of evidence was moderate for BW, low for FI and BMI, and very low for other outcomes. Walnut consumption was not associated with significant overall improvements in glycemic control or anthropometric parameters in adults. However, the findings should be interpreted cautiously given the overall low certainty of evidence and high risk of bias across the included studies. Although some subgroup analyses yielded statistically significant findings, these differences may not necessarily represent clinically meaningful effects. Further well‐designed, low‐risk‐of‐bias RCTs are warranted to clarify the potential effects of walnut consumption on glycemic and anthropometric outcomes.